Y. Du, “Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study ”, Dermatol Pract Concept, vol. 14, no. 1, p. e2024026, Jan. 2024, doi: 10.5826/dpc.1401a26.